A 2.4-mg weekly injection of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide led to a clinically meaningful 5% loss in weight for roughly two thirds of patients with both overweight/obesity and type 2 diabetes, researchers report. These findings from the Semaglutide Treatment Effect in People With Obesity 2 (STEP 2) trial, one of four phase
Steve Youngkin, 49, had always been a heavy child. The weight never seemed to go down. During his first marriage and soon after it ended, when Youngkin was in his early 30s, the weight seemed to go up even quicker. Each year came with new pants and new shirts, at one-point in size 6XL. Youngkin
Lexi Reed finally reached her goal weight, but then had another problem to solve: her excess skin. On January 1 of 2016, Lexi Reed and her husband, Danny, made a resolution to become healthier versions of themselves. At the time Lexi weighed in at 485 pounds. Not only did she not feel comfortable in her
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok